https://www.selleckchem.com/products/mmaf.html
73, 95% confidence interval (CI) 8.89-63.33, P less then 0.001; MELD OR 1.08, 95% CI 1.03-1.14, P = 0.003; ALBI OR 4.45; 95% CI 1.56-12.67, P = 0.005] and follow-up mortality [fibrosis hazard ratio (HR) 4.69, 95% CI 1.93-11.42, P = 0.001; MELD HR 1.07, 95% CI 1.04-1.10, P less then 0.001; ALBI HR 2.88, 95% CI 1.53-5.43, P = 0.001]. The association was further corroborated by a subgroup analysis. Conclusion Liver fibrosis and poor liver functional reserve could significantly increase the morbidity and mortality after TEVAR. APRI, MELD, and